This review article written by Meghana Kesireddy, MBBS and Matthew A. Lunning, MD, reviews management and treatment of relapsed/refractory large B-cell lymphoma.
Meghana Kesireddy, MBBS
Advertisement
Articles by Meghana Kesireddy, MBBS
Advertisement
Latest Updated Articles
Relapsed or Refractory Diffuse Large B-Cell Lymphoma: “Dazed and Confused”Published: June 16th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?
2
FDA Approves Liso-Cel in Marginal Zone Lymphoma After 2 Lines of Therapy
3
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
4
Silevertinib Displays Robust Antitumor Activity in EGFR-Mutated NSCLC
5
